Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Vendrely

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 27, 2007
[French national evaluation for helicoidal tomotherapy: description of indications, dose constraints and set-up margins]G Kantor, M-A Mahé, P Giraud, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 12, 2024
[Informed consent in radiotherapy care]C Sire, A Ducteil, J-L Lagrange, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 10, 2024
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trialT Conroy, F Castan, P-L Etienne, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 15, 2019
[Chemoradiation for oesophageal cancer: A critical review of the literature]E Blais, V Vendrely, P Sargos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancerD Azria, J Doyen, M Jarlier, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 27, 2007
[French national evaluation for helicoidal tomotherapy: description of indications, dose constraints and set-up margins]G Kantor, M-A Mahé, P Giraud, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 12, 2024
[Informed consent in radiotherapy care]C Sire, A Ducteil, J-L Lagrange, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 10, 2024
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trialT Conroy, F Castan, P-L Etienne, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 15, 2019
[Chemoradiation for oesophageal cancer: A critical review of the literature]E Blais, V Vendrely, P Sargos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancerD Azria, J Doyen, M Jarlier, et al.
Pageof 5